Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications (Prediction)
Sponsor: LivaNova
Listed as NCT00560768, this PHASE4 trial focuses on Sudden Cardiac Death and remains completed. Sponsored by LivaNova, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Dec 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LivaNova
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlanta, United States , Bad Oeynhausen, Germany , Berlin, Germany , Bochum, Germany , Bonn, Germany , Charlotte, United States , Clarks Green, United States , Coburg, Germany , Düsseldorf, Germany , Easton, United States and 15 more locations